2021 HAS STARTED AT CONSILIUM MUCH LIKE 2020 ENDED:
M&A, PROMOTIONS AND NEW HIRES
By Mary-Jane Elliott
At this point in a new year, many of us would be returning from a grueling schedule of meetings at the JP Morgan Healthcare Conference. Instead, this year, the fiber optic networks have been burning red hot as we’ve replaced bumping into each other on the hills of San Francisco with Zoom calls. Although media attention on the annual industry gathering has been more subdued than in typical years, the sentiment from clients is that schedules are packed with investor and partnering meetings and the world has adapted, just like it did throughout 2020.
At Consilium, COVID-19 still dominates the agenda for our clients. The ability of the sector to respond to the crisis has been breathtaking and it is has proven itself to be central to global attempts to get us back to normality. Investors and most governments are committed to recognising where support is needed to develop products and their commitment is not diminishing.
The appetite for healthcare innovation outside of COVID-19 is not abating. Proven by the active M&A market with three of our clients being acquired in the past few weeks: in late December 2020, we saw the agreed takeover of Horizon Discovery by Perkin Elmer for $383 million complete . In January Arvelle Therapeutics was acquired by Angelini Pharma for a total aggregate valuation of up to $960 million and Kymab was acquired by Sanofi for up to $1.45 billion with $1.1bn of that being up front – that’s the largest ever UK acquisition of a private healthcare company.
Behind the screens of Consilium, we have also seen notable changes. 2021 started with the promotion of Matthew Neal to Partner. This first internal promotion to Partner reflects our growth and maturation as a business as well as demonstrating our commitment to professional development and the recognition of talent. Alongside Matthew’s promotion, Priscila Radu, has been promoted to Associate and this followed a whole series of hires and promotions in 2020. To further support our growing business, we have also appointed two new Senior Associate Partners; we welcome Allison Connolly from Bloomberg and welcome back on old friend, Jessica Hodgson.
As we are not able to meet in person during these times, we have launched our new blog page, Consilium Conscience to update you on what’s happening in the healthcare sector, the capital markets, as well as at Consilium. As part of this, we have also launched a vlog and there will be a lot more digital content coming your way over the coming weeks and months.
Thank you to all our clients and collaborators for your continued support an importantly, to the Consilium team who continue to work tirelessly, keeping a sense of humour and positivity in these challenging times. We wish all our stakeholders a safe and successful 2021.d, most
Get the latest company updates from Consilium:
Movers and Shakers
See the latest City movers and shakers
Movers and Shakers
- Advanced Medical Solutions appointed Grahame Cook as a Non-Executive Director
- Silence Therapeutics appointed Craig Tooman as CFO and Michael H. Davidson to its Board of Directors
- Achilles Therapeutics appointed Arjan Roozen as VP, Site Head and General Manager
- Modulus Oncology appointed Tim Edwards as Chairman
- MeMed appointed Troy Boutelle as VP of Commercial in North America
- Candel Therapeutics appointed Paul-Peter Tak as President and CEO, Nathan Caffo as CBO, John Canepa as CFO and Susan Stewart as CRO
- iRhythm Technologies appointed Mike Coyle as CEO
- Sage Therapeutics appointed Barry Greene as CEO
- Myovant Sciences appointed Dave Marek as CEO
- Pfizer appointed Aida Habtezion as CMO
- ObsEva appointed David Renas as CFO
- MorphoSys appointed Sung Lee as CFO
- Checkmate Pharmaceuticals, Inc. appointed Robert Dolski as CFO
- 4D Molecular Therapeutics, Inc. appointed Robert Fishman as CMO
- Immune Regulation Ltd. appointed Jones Woody Bryan as CBO
- Evelo Biosciences, Inc. appointed Jonathan Zung as CDO
- AdrenoMed AG appointed Wolfgang Baike as CEO
- Pharma Two B Ltd. appointed Sheila Oren as CEO
- Union Therapeutics A/S appointed Kim Domela Kjoeller as CEO
- Myovant Sciences Ltd. appointed David C. Marek as CEO and Director
- PDS Biotechnology Corp. appointed Seth L. van Voorhees as Chief Financial and Accounting Officer
- CASI Pharmaceuticals, Inc. appointed Weihao Xu as Chief Financial and Accounting Officer
- Shanghai Henlius Biotech, Inc. appointed Xin Lei Li as CFO and Vice President
- Lykan Bioscience LLC appointed Patrick K. Lucy as CEO and President
- Cornerstone Therapeutics, Inc. appointed Jon Zwinski as CEO and President
- Immune Regulation Ltd. appointed Pericles Calias as COO
- Inventiva SA appointed Michael P. Cooreman as CMO
- Inhibikase Therapeutics, Inc. appointed C. Warren Olanow as CMO
- Immune Regulation Ltd. appointed Jeff Myers as CMO
- FibroGen, Inc. appointed Mark Eisner as CMO
- Saniona AB appointed Denelle J. Waynick as CLO
- Yumanity Therapeutics, Inc. appointed Paulash Mohsen as CFO and CBO and Marie N. Epstein as CAO
- Vincera Pharma, Inc. appointed Ahmed Hamdy as CEO, President and Chairman
Fundraising highlights
Highlighted fundraising activity this month
Fundraising highlights
|
Company Name |
Amount Raised |
Type of Fundraise |
Country |
Date |
|
Public company financings |
||||
|
Gracell Biotechnologies Inc. |
$209 million |
IPO |
China |
9-Jan-21 |
|
Inhibikase Therapeutics Inc. |
$18 million |
IPO |
US |
31-Dec-20 |
|
Arvinas Inc. |
$400 million |
Follow-on |
US |
17-Dec-20 |
|
AbCellera Biologics Inc. |
$555.5 million |
IPO |
Canada |
11-Dec-20 |
|
Private company Financings |
||||
|
Immunocore |
$75 million |
Series C |
UK |
11-Jan-21 |
|
Theolytics Ltd. |
$6.8 million |
Series A |
UK |
8-Jan-21 |
|
Abbisko Therapeutics Co. Ltd. |
$123 million |
Series D |
China |
8-Jan-21 |
|
DiCE Molecules SV LLC’s |
$80 million |
Series C |
US |
8-Jan-21 |
|
LifeMine Therapeutics Inc. |
$50 million |
Series B |
US |
8-Jan-21 |
|
Aulos Bioscience |
$40 million |
Series A |
US |
8-Jan-21 |
|
Mana Therapeutics Inc. |
$35 million |
Series A |
US |
8-Jan-21 |
|
Affinivax Inc. |
$236 million |
Series C |
US |
8-Jan-21 |
|
Lexeo Therapeutics |
$85 million |
Series A |
US |
7-Jan-21 |
|
Werewolf Therapeutics Inc. |
$72 million |
Series B |
US |
7-Jan-21 |
|
Senti Biosciences |
$105 million |
Series B |
US |
6-Jan-21 |
|
Immuneering Corp. |
$62 million |
Series B |
US |
5-Jan-21 |
|
Terns Pharmaceuticals Inc. |
$87 million |
Series C |
US |
5-Jan-21 |
|
Ikena Oncology Inc. |
$120 million |
Series B |
US |
5-Jan-21 |
|
Transcenta Holding Ltd. |
$105 million |
Cross-over |
China |
31-Dec-20 |
|
Risen (Shanghai) Pharmaceutical Technology Co. Ltd |
$61.1 million |
Series B |
China |
31-Dec-20 |
|
Aivita Biomedical Inc. |
$25 million |
Series B-2 |
US |
31-Dec-20 |
|
Aegicare (Shenzhen) Technology Co. Ltd. |
$15.4 million |
Series B |
China |
31-Dec-20 |
|
Eccogene (Shanghai) Co. Ltd. |
$15.4 million |
Undisclosed |
China |
31-Dec-20 |
|
Immunochina Pharmaceutical Co. Ltd. |
Undisclosed |
Series C++ |
China |
31-Dec-20 |
|
ImmVira Co. Ltd. |
Undisclosed |
Series C |
China |
31-Dec-20 |
|
AliveX |
Undisclosed |
Angel round |
China |
31-Dec-20 |
|
Galixir |
Undisclosed |
Undisclosed |
China |
31-Dec-20 |
|
Neomorph Inc. |
$109 million |
Series A |
US |
22-Dec-20 |
|
ONL Therapeutics Inc. |
$46.9 million |
Series B |
US |
21-Dec-20 |
|
Virtue Diagnostics (Suzhou) Co. Ltd. |
$2 million |
Series A |
China |
21-Dec-20 |
|
Peptilogics Inc. |
$35.4 million |
Series B |
US |
21-Dec-20 |
|
Raynovent Biotech Co. |
$42.9 million |
Series B |
China |
21-Dec-20 |
|
SomaLogic Inc |
$81 million |
Series A |
US |
21-Dec-20 |
|
Peptomyc S.L. |
$13.8 million |
Series B |
Spain |
17-Dec-20 |
|
Neurogene Inc. |
$115 million |
Series B |
US |
17-Dec-20 |
|
Atsena Therapeutics |
$55 million |
Series A |
US |
17-Dec-20 |
|
MinervaX |
$57.6 million |
Undisclosed |
Denmark |
17-Dec-20 |
|
Vivace Therapeutics Inc. |
$30 million |
Series C |
US |
17-Dec-19 |
|
Locanabio Inc. |
$100 million |
Series B |
US |
15-Dec-19 |
|
Rani Therapeutics LLC |
$69 million |
Series E |
US |
15-Dec-19 |
|
CG Oncology Inc. |
$47 million |
Series D |
US |
15-Dec-19 |
|
Denovo Biopharma LLC |
$45.8 million |
Series D |
US |
15-Dec-19 |
|
Biosion Inc. |
$30.6 million |
pre-Series B |
China |
15-Dec-19 |
|
HighTide Biopharmaceutical Ltd. |
Undisclosed |
Series B |
China |
15-Dec-19 |
|
InnoSkel |
$24.3 million |
Series A |
France |
14-Dec-19 |
|
Nuance Biotech |
$181 million |
Series D |
China |
9-Dec-19 |
|
Pear Therapeutics Inc. |
$80 million |
Series D |
US |
9-Dec-19 |
|
PepGen Ltd. |
$45 million |
Series A |
UK |
9-Dec-19 |
|
Vigil Neuroscience Inc. |
$50 million |
Series A |
US |
9-Dec-19 |
|
GenoImmune Therapeutics |
$15.3 million |
Series A+ |
China |
9-Dec-19 |
|
OBiO Technology (Shanghai) Co. |
$15.3 million |
Series C+ |
China |
9-Dec-19 |
|
Accutar Biotechnology Inc. |
Undisclosed |
Undisclosed |
US |
9-Dec-19 |
|
Deepcell Inc. |
$20 million |
Series A |
US |
9-Dec-19 |
|
RayzeBio |
$105 million |
Series B |
US |
8-Dec-19 |
Analyst directory
View our Analyst Directory
Analyst directory
|
Bank |
Analyst |
|
ABG Sundal Collier |
Morten Larsen, Daniel Thorsson |
|
ABN AMRO |
Mark van der Geest, Rene Verhoeff |
|
Alm. Brand Markets |
Michael Friis Jørgensen |
|
AlphaValue |
Armelle Moulin, Marion Scherzinger |
|
Banco de Sabadell, S.A. |
Javier Esteban |
|
Banco Espirito Santo de Investimento |
Luis Navia |
|
Bank am Bellevue |
Bruno Eschli, Stephen Leventhal |
|
Bankhaus Lampe KG |
Heiko Feber, Frank Neumann |
|
Bank Vontobel AG |
Carla Baenziger |
|
Barclays |
Hassan Al-Wakeel, Blanka Porkolab, Emily Field, Jameel Bakhsh, Brian Balchin, Peter Lawson |
|
Berenberg Bank |
Scott Bardo, Luisa Hector, Kerry Holford, Tom Jones, Ravi Misra, Xian Deng, Michael Healy, Esther Hong, Iris Zhilin Long, Zhiqiang Shu, Yun Zhong (David Hogg) |
|
Bank of America Merrill Lynch |
Aspen Mori (NY), Graham Parry (London), Qian Weng, John Aldersley (Dan Lundquist) |
|
Bryan, Garnier & Co |
Dylan van Haaften, Eric Le Berrigaud, Ross Blair, Mickael Chane-Du, Marion Levi, Hugo Solvet, Vincent Meunier, (Dominic Wilson) |
|
CA Cheuvreux |
Marcel Brand, Laurent Flamme, Richard Koch, Oliver Reinberg |
|
Caja Madrid Bolsa |
Ana Isabel González García |
|
Carnegie Bank |
Niels Granholm, Philip Lagnetoft, Kristofer Liljeberg-Svensson, Carsten Lonborg Madsen, Henrik Sinding, Lars Topholm |
|
Cenkos Securities |
Chris Donnellan |
|
Citigroup |
Liav Abraham (US), Andrew Baum, Alex Glasner, Peter Verdult, Patrick Wood, (David Rawley) |
|
CM-CIC Securities |
Agnès Blazy, Arsene Guekam |
|
Commerzbank |
Volker Braun, Daniel Wendorff |
|
Cowen International |
David Kirkpatrick, Ritu Baral, Ryan Blicker, Ken Cacciatore, Marc Frahm, Joshua Jennings, Chris Lin, Charles Rhyee, Doug Schenkel, Yaron Weber |
|
Credit Suisse |
Christoph Gretler, Evan Seigerman, Matt Miksic Barbora Blaha, Jo Walton, Matthew Weston, (Phil Gestrin) |
|
Danske Equities |
Thomas Bowers, Mattias Häggblom, Hans Jeppsson, Martin Parkhøi, Søren Samsøe |
|
Deutsche Bank |
Emmanuel Papadakis, Rajan Sharma, Justin Bowers, Jack McKibben, Farzana Habib, Katie Kraft, Jeremy Finkelstein, Andrew Vincent |
|
Degroof Petercam |
Thomas Guillot, Benoit Louage, Chris Keepers |
|
DnB NOR |
Rune Dahl |
|
DZ Bank |
Christa Bähr, Elmar Kraus, Thomas Maul, Peter Spengler |
|
Edison |
John Priestner, Susie Jana, John Savin, Jonas Peciulis, Sean Conroy, Maxim Jacobs, Nathaniel Calloway , Pooya Hemami |
|
Equinet Institutional Services |
Edouard Aubery |
|
Equity Development |
Emma Ulker |
|
Exane BNP Paribas |
Richard Parkes, Alex Evans, Julien Dormois, Hugo Solvet, Nicolas Langlet, Kartik Swaminathan |
|
fairesearch GmhH & Co |
Martin Schnee |
|
finnCap |
Mark Brewer, Arshad Ahad, Nik Lysiuk |
|
Goetz Partners |
Melina Reisenberg, Chris Redhead |
|
Goldman Sachs |
Krishna-Chaitanya Arikatla, Veronika Dubajova, Divya Harikesh, Keyur Parekh, Graig Suvannavejh, Joanna Tucka, Kira Huppertz, (Mick Readey) |
|
Handelsbanken Capital Markets |
Klaus Madsen, Björn Olander, Peter Sehested |
|
Hardman and Co |
Martin Hall, Gregoire Pave |
|
Helvea |
Daniel Jelovcan, Odile Rundquist, Olav Zilian |
|
HSBC |
Steve McGarry, Julie Mead, Lucy Acton, Murielle André-Pinard |
|
ING |
Sjoerd Ummels, David Vagman |
|
Investec |
Andrew Whitney, Jens Lindqvist, (Brough Ransom) |
|
Jefferies |
Harry Sephton, Grace Lee, Lucy Codrington, Philippa Gardner, Kit Lee, Ken Rumph, James Vane-Tempest, Peter Welford, Ing Shen Tan, Erin Primdahl, (Jan Scherer) |
|
JP Morgan Cazenove |
David Adlington, Alex Comer, James Gordon, Richard Vosser, Marjan Daeipour |
|
KBC Securities |
Sandra Cauwenberghs, Lenny Van Steenhuyse |
|
Kempen & Co |
Alexander Cogut, Rene Wouters, Suzanne van Voorthuizen, Ingrid Gafanhão, Sebastiaan van der Schoot |
|
Kepler Capital Markets |
Arsene Gekam, Damien Choplain, David Evans, Maja Pataki, Martin Voegtli, Matthias Maenhaut |
|
Landesbank Baden-Wuerttemberg |
Timo Kuerschner |
|
Liberum Capital |
Alistair Campbell, Graham Doyle |
|
Morgan Stanley |
Alex Gibson, Michael Jungling, Simon Mather, Jenny Leeds |
|
N+1 Singer |
Chris Glasper, Edward Thomason, Sahill Shan |
|
Natixis Beatrice |
Philipe Lanone, Jean-Jacques Le Fur |
|
Nordea Markets |
Klas Pyk |
|
Nord/LB |
Holger Fechner, Thorsten Strauss |
|
Numis |
Paul Cuddon, Stefan Hamill, (Ceri Morgan) |
|
Oddo Securities |
Martial Descoutures, Oussama Denguir |
|
Panmure Gordon |
Mike Mitchell, Julie Simmonds, (David Cox) |
|
Pareto Securities |
Finlay Heppenstall, Ulrik Trattner |
|
Peel Hunt |
Miles Dixon, Anchal Verma, Amy Walker |
|
Portzamparc Gestion S.A. |
Christophe Dombu |
|
RBC Capital Markets |
Zoe Karamanoli (maternity), Charles Weston, Jack Reynolds-Clarke |
|
Redburn |
Simon Baker, Darshan R., Issie Kirby, Charles Pitman, Robert Shore, Ed Ridley-Day |
|
Rx Securities |
Samir Devani, Joseph Hedden, Michael King, Ross Blair |
|
Sanford C Bernstein |
Lisa Clive |
|
Santander |
Rebecca McClellan, Alejandro Conde Fraisolí, Tomasz Krukowski, |
|
SEB Enskilda |
Lars Hevreng, Henrik Simonsen, Peder Strand |
|
Shore Capital |
Adam Barker, Tara Raveendran |
|
Société Générale |
Florent Cespedes, Patrick Jousseaume, Delphine Le Louët, Justin Smith |
|
Standard & Poors |
Sho Matsubara, Jacob Thrane |
|
Stifel |
Christian Glennie, Max Herrmann, James Osborne (Erland Sternby) |
|
Swedbank |
Johan Unnerus |
|
Trinity Delta |
Lala Gregorek, Franc Gregori |
|
UBS |
Laura Sutcliffe, Michael Leuchten, Jack Scannell, Sebastien Walker |
|
Zürcher Kantonalbank |
Michael Nawrath |
Media directory
View our Media Directory
Media directory
BBC Fergus Walsh, Hugh Pym, James Gallagher, Katie Hope, Alex Therrien
Boston Business Journal Lucy Maffei, Don Seiffert, Max Stendahl
Boston Globe Jonathan Saltzman
Boston Herald Jordan Graham
Business Insider Erin Bromley, Lydia Ramsey, Zach Tracer
Daily Express Mark Atherton, Becky Fletcher, Giles Sheldrick
Daily Mail Vanessa Chalmers, Jonathan Chadwick, Ethan Ennals, Anna Hodgekiss, Fiona Macrae, Matt Oliver, Rachel Reilly, Ben Spencer, Alexandra Thompson, Sally Wardle, Victoria Woollaston
Daily Telegraph, Julia Bradshaw, Laura Donnelly, Anne Gulland, Sarah Knapton, Chloe Lambert, Hannah Uttley, Hannah Boland, Jon Yeomans, Louise Moon
Financial Times Clive Cookson, Darren Dodd, Anna Gross, Sarah Neville, Gill Plimmer, Barney Thompson (UK); Hannah Kuchler (US)
Forbes Steve Brozak, Bruce Japsen, Leah Rosenbaum
Fortune Sy Mukherjee
Inc. Kimberly Weisul
Mail on Sunday Stephen Adams, Joanne Hart, Eve Simmons, Alex Lawson
Sky News Mark Kleinman, Paul Kelso, Thomas Moore
The Guardian Sarah Boseley, Denis Campbell, Hannah Devlin, Natalie Grover, Julia Kollewe, Linda Geddes
The New York Times Gina Kolata, Andrew Pollack, Sabrina Tavernise, Katie Thomas
The Sunday Times John Collingridge, Andrew Gregory, Jonathan Leake, Sabah Meddings, Lois Rogers, Oliver Shah, Jamie Nimmo
The Times Philip Aldrick, Kaya Burgess, Richard Fletcher, Tom Howard, Graham Ruddick, Kat Lay, Fiona MacRae, Alex Ralph, Dominic Walsh
The Wall Street Journal Brian Gormley, Daniela Hernandez, Jared Hopkins (US); Robert Lee Hotz, Stefanie Ilgenfritz, Peter Loftus (US); Amy Dockser Marcus, Jonathan Rockoff (US); Denise Roland (Europe, maternity leave); John Simons, Joseph Walker, Jeanne Whalen, Anna Wilde Mathews (US)
The Washington Post Carolyn Johnson
S&P Global Etain Lavelle, Kristen Hallam
APM Health Europe Nick Hudson, Thomas Meek, Natalie Morrison, Eliza Slawther
Associated Press Tom Murphy
Bloomberg Naomi Kresge (Berlin); Albertina Torsoli (Geneva); John Lauerman (Boston), James Paton (London); Drew Armstrong (New York); Marthe Fourcade (Paris); Tim Loh (Munich)
Dow Jones Matteo Castia, Ian Walker, Philip Waller
fastFT Jennifer Thompson
Thomson Reuters Kate Kelland, Paul Sandle
AnimalPharm Joseph Harvey
BioCentury Stephen Hansen (UK); Jonathan Block, Paul Bonanos, Jeff Cranmer, Simone Fishburn, Dave Flores, Virginia Li, Chris Lieu, Lauren Martz, Erin McCallister, Alicia Parker, Susan Schaeffer, Mark Zipkin (US)
BioWorld MedTech Bernard Banga, John Brosky, David Godkin, Larry Haimovitch, Stacy Lawrence, Nuala Moran, Katie Pfaff
BioWorld Shannon Ellis, Michael Fitzhugh, John Fox, Brian Orelli, Randy Osborne, Alfred Romann, Tamra Sami, Cormac Sheridan, Nuala Moran
Endpoints Arsalan Arif, John Carroll, Jason Mast, Amber Tong, Conner Mitchell
Genome Web Ben Butkus, Molika Ashford, Monica Heger, Madeleine Johnson
Fierce Life Sciences Ben Adams, Nick Paul Taylor (UK); Amirah Al Idrus, Michael Gibney, Conor Hale, Carly Helfand, Mark Hollmer, Emily Mullin, Eric Palmer, Tracy Staton, Emily Wasserman (US)
FirstWord Medtech Tina Tan
Healthcare Business International Max Hotopf
HealthInvestor Jonathan Bacon, Vernon Baxter, Sunniva Davies-Rommetveit, Catherine Llewllyn, Jenna Lomax, Ploy Radford
IN VIVO Lucie Ellis (UK); Ben Comer (US)
Investors Chronicle Harriet Clarfelt, Emma Powell, Mark Robinson
Labiotech Clara Rodríguez Fernández, Jonathan Smith
MedCityNews Alaric DeArment
MedNous Victoria English, Karen Finn
Medtech Insight Jenny Blair, Philip Greenfield (UK); Reed Miller (US)
Nature Biotechnology Lisa Melton
Pharmaphorum Catherine Longworth, Richard Staines, George Underwood
PharmaTimes Selina McKee, Anna Smith
Scrip John Davis, Kevin Grogan, Eleanor Malone, Andrew McConaghie, Alex Shimmings (UK); Joseph Haas, Mandy Jackson, Mary Jo Laffler, Jessica Merrill, Denise Peterson (US); Anju Ghangurde, Ian Haydock (Asia-Pacific)
Shares Magazine Martin Gamble
Sifted Michael Stothard, John Thornhill, Maija Palmer, Amy Lewin, Chris Sisserian, Isabel Woodford, Nicolas Colin, Kitty Knowles (UK), Mimi Billing, Tim Smith (Spain), Tom Turula (Sweden), Marie Mawad (France)
STAT Adam Feuerstein, Damian Garde, Matthew Herper, Meghana Keshavan, Rebecca Robbins, Ed Silverman, Mario Aguilar, Katie Palmer
The Economist Catherine Brahic, Slavea Chankova, Alice Fulwood, Alok Jha, Natasha Loder
The Pink Sheet Neena Brizmohun, Francesca Bruce, Maureen Kenny, Ian Schofield, Vibha Sharma (UK); Nielsen Hobbs, Sue Sutter (US)
Timmerman Report Luke Timmerman
Vantage Lisa Urquhart, Madeleine Armstrong, Amy Brown, Elizabeth Cairns, Jacob Plieth (UK)
Xconomy Alex Lash, Frank Vinluan, Greg Huang